New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: HRK-PF-04971729
• Product Name: PF-04971729 Powder
• Appearance: White or White Crystalline Powder
• Test: HPLC
• Mf: C22h25clo7
• CAS: 1210344-57-2
• MW: 436.129
• Active Ingredient: PF-04971729
• Sample: Ertugliflozin Avaliable
• Certificate: GMP ISO USP Bp
• Assay: 90% Min
• Grade Standard: Feed Grade, Food Grade, Medicine Grade
• Application: PF-04971729 Raw Materials
• Type of Product: Auxiliaries and Other Medicinal Chemicals
• Storage: Cool Dry Place
• Shelf Life: 2 Years Proper Storage
• Transport Package: 1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr
• Specification: 99% min PF-04971729
• Trademark: Henrikang
• Origin: Shaanxi China
• Production Capacity: 500000kg/Year

Product Description

                   New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729

Product Name	New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729
CAS	1210344-57-2
Appearance	White or white crystalline powder
Molecular formula	C22H25ClO7
Molecular Weight	436.129
Assay	98%
Shelf Life	24 months when properly stored
Storage	Keep in a cool, dry, dark location

 

What is Ertugliflozin? Ertugliflozin is an antidiabetic drug. Ertugliflozin is used to improve glycemic control in people with type 2 diabetes,Egagliflozin is a new class of SGLT2 inhibitors co-developed by Pfizer and Merck. In December 2017, the US FDA approved its marketing under the trade name Steglatro. It has been clinically used in the treatment of adult patients with type 2 diabetes, but it has not been marketed in China. Ertugliflozin series impurities are used for research and examination of related substances in ertugliflozin drug research.

Function of Ertugliflozin

Temozolomide is used in the treatment of adults with refractory pleomorphic glioblastoma and anaplastic
astrocytoma of chemotherapy drugs.Egagliflozin is a new class of SGLT2 inhibitors co-developed by Pfizer
and Merck. In December 2017, the US FDA approved its marketing under the trade name Steglatro. It has
been clinically used in the treatment of adult patients with type 2 diabetes, but it has not been marketed in
China. Ertugliflozin series impurities are used for research and examination of related substances in ertugliflozin
drug research.

 
Company Information




Our Certificate


Our Service


Our Research


Packaging & Logistics

Package:

1kg per Foil Bag, 10 Bags per carton. 25 kg per Drum. Or Customized Package.
 

2. Shipping Advise: 

1. By Express

------Suitable for under 50kg, Fast:3-4 days. High cost; Door to door service. Easy to pick up the goods.

2. By Air 

------Suitable for more than 50 kg, Fast:4-5 days, High cost, airport to airport. professional broker needed.

3. By sea

------Suitable for more than 500kg. Slow: 15-45 days, Low cost. Port to Port, professional broker needed.

why choose us ?

New Antidiabetes Pharmaceutical PF-04971729 CAS 1210344-57-2 Ertugliflozin PF-04971729
Ertugliflozin;PF-04971729;Ertugliflozin Powder